Pancreas Regeneration refers to the ability of the pancreas to repair and replace damaged or lost cells, with the ultimate goal of restoring its structure and function. The pancreas is a vital organ involved in both endocrine and exocrine functions, producing hormones like insulin and enzymes for digestion. Understanding and harnessing the regenerative capacity of the pancreas has significant implications for treating conditions such as diabetes and pancreatitis. In healthy individuals, the pancreas undergoes continuous turnover and regeneration to maintain tissue homeostasis. This process involves the proliferation and differentiation of various cell types, including beta cells responsible for insulin production and acinar cells responsible for enzyme secretion. However, the regenerative capacity of the pancreas is limited, and certain injuries or diseases can impair its ability to recover fully. Research in pancreas regeneration focuses on identifying the cellular mechanisms and signaling pathways involved in tissue repair. Stem cells, both within the pancreas and from other sources, are a key focus of investigation. The differentiation of stem cells into insulin-producing beta cells holds promise for replenishing the pancreatic cell population in conditions like type 1 diabetes, where beta cell destruction occurs. Various factors influence pancreas regeneration, including growth factors, cytokines, and the extracellular matrix. In experimental settings, researchers explore the potential of manipulating these factors to enhance pancreatic regeneration and improve outcomes in disease settings. Islet transplantation, a form of cell therapy, represents another avenue for promoting pancreas regeneration. By transplanting insulin-producing islets into the pancreas, researchers aim to restore normal glucose regulation in individuals with diabetes. Advances in cell engineering and transplantation techniques contribute to the ongoing efforts to optimize islet transplantation as a regenerative therapy. While significant progress has been made, challenges remain in fully unlocking the regenerative potential of the pancreas. Balancing the regeneration of different cell types, preventing immune rejection in transplantation, and addressing the complexity of diabetes are among the ongoing research priorities. Successful pancreas regeneration strategies hold the promise of transformative treatments for diabetes and other pancreatic disorders.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy